FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2038506087> ?p ?o ?g. }

• W2038506087 endingPage "97" @default.
• W2038506087 startingPage "89" @default.
• W2038506087 abstract "Attention-deficit/hyperactivity disorder (ADHD) is a heterogeneous neurobehavioural disorder. Several lines of evidence have implicated monoamine signalling systems, including transporters and receptors, in the pathogenesis of ADHD. We explored the heterogeneity of neural mechanisms that may possibly underlie symptomatic abnormalities in ADHD, by investigating the effects of monoamine reuptake inhibitors with differential spectrums for each monoamine transporter on ADHD-like behaviours in an animal model of ADHD, i.e. juvenile (6-week-old) male stroke-prone spontaneously hypertensive rats (SHRSP/Ezo). The impaired spontaneous alternation performance in a Y-maze task, demonstrated the inattentive features of SHRSP/Ezo, was improved by a selective DA reuptake inhibitor GBR-12909 (1 and 3mg/kg, i.p.). Desipramine (1, 3 and 10mg/kg, i.p.) and milnacipran (30mg/kg, i.p.), which possess a noradrenaline (NA) reuptake inhibitory activity, also ameliorated inattentive behaviour. Increased locomotor activity in open-field apparatus and total arm entries in a Y-maze task, which demonstrate the hyperactive features of SHRSP/Ezo, were improved by desipramine and milnacipran, but impaired by a high dose of GBR-12909 (10mg/kg, i.p.). A selective serotonin (5-HT) reuptake inhibitor fluvoxamine (10 and 30mg/kg, i.p.), did not affect inattention but significantly suppressed hyperactivity at a high dose (30mg/kg, i.p.). Moreover, a low dose of fluvoxamine (3mg/kg, i.p.) ameliorated the increased open arm spent time in an elevated plus-maze without affecting total arm entries, indicating an effect on impulsive features based on the anxiolytic characteristics of SHRSP/Ezo. These behavioural effects of monoamine reuptake inhibitors support the heterogeneity of monoaminergic systems, which are responsible for ADHD-like behaviours in SHRSP/Ezo. These findings may provide pharmacological evidence for the development of ADHD treatments that target more appropriate monoamine transporters." @default.
• W2038506087 created "2016-06-24" @default.
• W2038506087 creator A5002444455 @default.
• W2038506087 creator A5004690924 @default.
• W2038506087 creator A5021224719 @default.
• W2038506087 creator A5047019247 @default.
• W2038506087 creator A5056802168 @default.
• W2038506087 creator A5059868098 @default.
• W2038506087 creator A5061044019 @default.
• W2038506087 date "2013-04-01" @default.
• W2038506087 modified "2023-10-16" @default.
• W2038506087 title "Behavioural effects of monoamine reuptake inhibitors on symptomatic domains in an animal model of attention-deficit/hyperactivity disorder" @default.
• W2038506087 cites W1493305388 @default.
• W2038506087 cites W1552361108 @default.
• W2038506087 cites W163350356 @default.
• W2038506087 cites W1764010569 @default.
• W2038506087 cites W1977542480 @default.
• W2038506087 cites W1978219303 @default.
• W2038506087 cites W1981701086 @default.
• W2038506087 cites W1987883688 @default.
• W2038506087 cites W1989057449 @default.
• W2038506087 cites W2007209042 @default.
• W2038506087 cites W2007311340 @default.
• W2038506087 cites W2008226573 @default.
• W2038506087 cites W2011083427 @default.
• W2038506087 cites W2014653427 @default.
• W2038506087 cites W2015104943 @default.
• W2038506087 cites W2019598848 @default.
• W2038506087 cites W2021223587 @default.
• W2038506087 cites W2041561931 @default.
• W2038506087 cites W2042123414 @default.
• W2038506087 cites W2043024252 @default.
• W2038506087 cites W2043185143 @default.
• W2038506087 cites W2044907318 @default.
• W2038506087 cites W2047601130 @default.
• W2038506087 cites W2056111332 @default.
• W2038506087 cites W2058765435 @default.
• W2038506087 cites W2066907505 @default.
• W2038506087 cites W2086182815 @default.
• W2038506087 cites W2088465383 @default.
• W2038506087 cites W2091110888 @default.
• W2038506087 cites W2091855875 @default.
• W2038506087 cites W2092953670 @default.
• W2038506087 cites W2094437656 @default.
• W2038506087 cites W2096311792 @default.
• W2038506087 cites W2098017886 @default.
• W2038506087 cites W2098273438 @default.
• W2038506087 cites W2108628211 @default.
• W2038506087 cites W2108825746 @default.
• W2038506087 cites W2112098409 @default.
• W2038506087 cites W2120827437 @default.
• W2038506087 cites W2138650653 @default.
• W2038506087 cites W2141798080 @default.
• W2038506087 cites W2148863165 @default.
• W2038506087 cites W2171878002 @default.
• W2038506087 cites W2409126490 @default.
• W2038506087 cites W4230397009 @default.
• W2038506087 cites W4245708356 @default.
• W2038506087 cites W4376633676 @default.
• W2038506087 doi "https://doi.org/10.1016/j.pbb.2013.01.009" @default.
• W2038506087 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23380523" @default.
• W2038506087 hasPublicationYear "2013" @default.
• W2038506087 type Work @default.
• W2038506087 sameAs 2038506087 @default.
• W2038506087 citedByCount "15" @default.
• W2038506087 countsByYear W20385060872014 @default.
• W2038506087 countsByYear W20385060872015 @default.
• W2038506087 countsByYear W20385060872016 @default.
• W2038506087 countsByYear W20385060872018 @default.
• W2038506087 countsByYear W20385060872019 @default.
• W2038506087 countsByYear W20385060872020 @default.
• W2038506087 countsByYear W20385060872022 @default.
• W2038506087 crossrefType "journal-article" @default.
• W2038506087 hasAuthorship W2038506087A5002444455 @default.
• W2038506087 hasAuthorship W2038506087A5004690924 @default.
• W2038506087 hasAuthorship W2038506087A5021224719 @default.
• W2038506087 hasAuthorship W2038506087A5047019247 @default.
• W2038506087 hasAuthorship W2038506087A5056802168 @default.
• W2038506087 hasAuthorship W2038506087A5059868098 @default.
• W2038506087 hasAuthorship W2038506087A5061044019 @default.
• W2038506087 hasConcept C109344038 @default.
• W2038506087 hasConcept C118552586 @default.
• W2038506087 hasConcept C126322002 @default.
• W2038506087 hasConcept C15744967 @default.
• W2038506087 hasConcept C170493617 @default.
• W2038506087 hasConcept C173586616 @default.
• W2038506087 hasConcept C176233148 @default.
• W2038506087 hasConcept C187714386 @default.
• W2038506087 hasConcept C2775864247 @default.
• W2038506087 hasConcept C2776134451 @default.
• W2038506087 hasConcept C2777112843 @default.
• W2038506087 hasConcept C2778897192 @default.
• W2038506087 hasConcept C2779177272 @default.
• W2038506087 hasConcept C2779910183 @default.
• W2038506087 hasConcept C2780092697 @default.
• W2038506087 hasConcept C2780199185 @default.
• W2038506087 hasConcept C2780250439 @default.
• W2038506087 hasConcept C2780783007 @default.

• next